Heart and Vascular
- CHAMPION PCI
Acute Coronary Syndrome ( Undergoing PCI )
This Phase III clinical trial is evaluating cangrelor, a fast-acting, reversible, intravenous (IV) antiplatelet agent for preventing platelet activation and aggregation during the clotting process, in patients undergoing coronary procedures ( e.g. PCI ).
- PFO ACCESS Registry
(Stroke patients with presumed embolism through a PFO)
The primary objective of the PFO ACCESS Registry is to allow access to the APLATZER PFO Occluder in subjects with a PFO who have already experienced at least two cryptogenic strokes fue to presumed paradoxical embolism through a patent foramen ovale (PFO) and who have failed conventional drug therapy.
- Visipaque
( Patients with Unknown Coronary Artery Disease undergoing Coronary CTA )
This is a Phase IV registry study for patients with chest pain syndrome and an intermediate pre-test probability of CAD undergoing coronary computed tomography angiography (CCTA) examination as part of a routine work up. This study is being conducted to compare the CCTA scan (CT scan of the heart) results with any heart related problems the patient may have 1-month, 6-months and 12-months after the scan.